These revealed similar peptide binding modes to that previously observed for GLP-1
Two collagen types dominate: Type I collagen (mature tendon structure) Type III collagen (early repair phase) In rodent studies, BPC-157-treated tendons showed: Increased type I collagen deposition Improved fiber parallel alignment Better biomechanical strength This suggests influence over: TGF- signalling Matrix metalloproteinases (MMPs) Extracellular matrix remodelling enzymes Balanced ECM remodelling prevents disorganized scar tissue
The optimal needle size for subcutaneous peptide injections is 30G x 8mm
A new, sterile syringe and needle must be used for every single puncture of any vial
Rafalski M, Ortiz A, Rockwell A, Van Ginkel LC, Lear JD, DeGrado WF, et al
#SalubrisPharmaceuticals #ClinicalTrialApproval #InnovativeMedicines #SmallMoleculeDrugDevelopment #Hyperlipidemia #StrategicPartnerships #BusinessDevelopment #CollaborationOpportunities To view or add a comment, sign in A milestone for oral peptide delivery: Wegovy goes oral Novo Nordisk has just reached a major milestone with the FDA approval of oral Wegovy (semaglutide) the first oral GLP-1 therapy approved for chronic weight management
